Vant AI

Vant AI is owned by Sumitomo Chemical.

Sumitomo Chemical is one of the...

• Forbes Global 2000 (#1009);
• Nikkei 225;
• Topix.

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 28 subsidiaries including Asahi Chemical, Ciox Health and Covant Therapeutics.

They are in:

• Biotechnology55%
• Chemicals24%
• Other21%

View the org chart displaying its 8 main executives

Most searched biographies at Vant AI

• Zachary Carpenter, Chief Executive Officer
• Luca Naef, Chief Technology Officer
• Michael Bronstein, Chief Scientist in Residence

Popular executive movements at Vant AI

• Jae Won Kim has joined the company as Chief Operating Officer and Chief Financial Officer  (posted on February 8 2024).

Create your alert
to follow the executive moves at Vant AI.

Sumitomo Chemical has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Vant AI

Social media about Vant AI

• Vant AI on Wikipedia, Google News & Yahoo Finance
• Vant AI on LinkedIn, Twitter & YouTube

Contact by email its executives including Michael Bronstein

Call Vant AI at +1 347...

View the org chart

Register to receive your alert

Report an error